|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
ADRIAMYCIN PFS (doxorubicin hydrochloride injection), Pharmacia & Upjohn Company NDA 50-467/S-064/S-067 & 50-629/S-010/S-013 Doxil (doxorubicin HCl liposome) Injection, ALZA NDA 50-718/S-016 12/17/02 Doxil (doxorubicin HCl liposome) Injection, ALZA NDA 50-718/S-010 1/10/02 2/8/02 Doxil (doxorubicin HCl liposome) Injection, 50 mg/m2, ALZA NDA 50-718/S-006 6/28/99 6/30/99 6/30/99 Doxil Injection: treatment of metastatic carcinoma of the ovary in patients with disease that is refractory to both paclitaxel- and platinum-based chemotherapy regimens. Doxorubicin Hydrochloride Injection, 10, 20, 50, and 150 & 10, 20, 50, 75, 150, and 200 mg, Pharmacia & Upjohn Company NDA 50-467/S-068/S-069 & 50-629/S-014/S-016 | Doxil (doxorubicin HCl liposome) injection, Johnson & Johnson Pharma, Efficacy Supplement with Clinical Data to Support | Doxil (doxorubicin HCl liposome injection), Alza Corp, Accelerated Approval | Doxil (Doxorubicin HCI Liposomal Injection), Alza Corp., Accelerated Approval
|